Paul Alloway Net Worth & Insider Trades

Paul Alloway - See Remarks, Homology Medicines, Inc

As of March 6, 2023

What is Paul Alloway's Net Worth?

The current estimated net worth of Homology Medicines, Inc's See Remarks, Paul Alloway, is estimated to be about $50.31K . Paul Alloway owns about 16,706 units of Homology Medicines, Inc common stock. In the last 2 months at Homology Medicines, Inc, Paul Alloway has sold an estimated value of $20.16K worth.

What is Paul Alloway's Past Insider Trading?

Paul Alloway's largest sale order was 10,965 units , worth over $15.86K on March 6, 2023. In total, Paul Alloway has made about 4 transactions over 2 months of their time at Homology Medicines, Inc. Paul Alloway usually trades in January, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Paul Alloway's' Mailing Address?

  • Mailing address is C/o Homology Medicines, Inc. 45 Wiggins Avenue Bedford MA 01730 MA

Homology Medicines, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Arthur O. Tzianabos, Ph.D. 2020 $563,200 - - $309,760 $13,000 $885,960
Arthur O. Tzianabos, Ph.D. 2019 $537,600 - $4,217,097 $295,680 $12,500 $5,062,877
Albert Seymour, Ph.D. 2020 $426,800 - - $170,720 $10,057 $607,577
Albert Seymour, Ph.D. 2019 $405,600 - $1,295,756 $162,240 $13,231 $1,876,827
W. Bradford Smith 2020 $406,700 - - $162,680 $13,000 $582,380
W. Bradford Smith 2019 $384,200 - $1,307,536 $153,680 $14,880 $1,860,296
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1661998/000156459021021931/fixx-def14a_20210617.htm

What are Homology Medicines, Inc's Past Insider Trades?

Homology Medicines, Inc's most recent insider trade came on September 8, 2023 by Albert Seymour who sold 1,448 units worth $1.67K . In the last 5 years, insiders at Homology Medicines, Inc have sold an estimated value of $109.56M and bought an estimated value of $60.18M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Albert Seymour, See Remarks,  Arthur Tzianabos,  and W. Bradford Smith, See remarks .

Homology Medicines, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...